| scholarly article | Q13442814 |
| P356 | DOI | 10.1083/JCB.116.1.187 |
| P953 | full work available at URL | http://rupress.org/jcb/article-pdf/116/1/187/1062336/187.pdf |
| https://europepmc.org/articles/PMC2289262 | ||
| https://europepmc.org/articles/PMC2289262?pdf=render | ||
| P932 | PMC publication ID | 2289262 |
| P698 | PubMed publication ID | 1730743 |
| P5875 | ResearchGate publication ID | 277504668 |
| P2093 | author name string | M. G. Brattain | |
| D. Theodorescu | |||
| R. S. Kerbel | |||
| K. M. Mulder | |||
| J. K. Willson | |||
| L. E. Humphrey | |||
| S. P. Wu | |||
| P2860 | cites work | DNA sequencing with chain-terminating inhibitors | Q22066207 |
| Purification of Biologically Active Globin Messenger RNA by Chromatography on Oligothymidylic acid-Cellulose | Q24563043 | ||
| A new type of transforming growth factor-beta, TGF-beta 3 | Q24564095 | ||
| Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease | Q26778460 | ||
| Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells | Q28305879 | ||
| Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter | Q29614259 | ||
| The transforming growth factor-beta family | Q29615948 | ||
| Characterization of human colon carcinoma cell lines isolated from a single primary tumour | Q36047559 | ||
| Some recent advances in the chemistry and biology of transforming growth factor-beta | Q36217584 | ||
| The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection | Q36320006 | ||
| Cloning and sequence analysis of simian transforming growth factor-beta cDNA. | Q36459187 | ||
| Base composition-independent hybridization in tetramethylammonium chloride: a method for oligonucleotide screening of highly complex gene libraries | Q36486519 | ||
| Retinoic acid induces transforming growth factor-beta 2 in cultured keratinocytes and mouse epidermis | Q36734355 | ||
| Complex regulation of transforming growth factor beta 1, beta 2, and beta 3 mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factors beta 1 and beta 2. | Q36797770 | ||
| Efficient detection of soft agar grown colonies using a tetrazolium salt | Q39421792 | ||
| Heterogeneity of human colon carcinoma | Q40214753 | ||
| Differential regulation of c-myc and transforming growth factor-alpha messenger RNA expression in poorly differentiated and well-differentiated colon carcinoma cells during the establishment of a quiescent state | Q41685353 | ||
| Transforming growth factor beta 1 acts as an autocrine-negative growth regulator in colon enterocytic differentiation but not in goblet cell maturation | Q41711232 | ||
| Inhibitory effects of transforming growth factor beta 1 on mitogenic response, transforming growth factor alpha, and c-myc in quiescent, well-differentiated colon carcinoma cells | Q41713918 | ||
| Growth inhibition of a human lymphoma cell line: induction of a transforming growth factor-beta-mediated autocrine negative loop by phorbol myristate acetate | Q41717171 | ||
| Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta | Q41726343 | ||
| Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation | Q41728185 | ||
| Human transforming growth factor-beta 3: recombinant expression, purification, and biological activities in comparison with transforming growth factors-beta 1 and -beta 2. | Q41759066 | ||
| Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells | Q42799828 | ||
| Coincidental Acquisition of Growth Autonomy and Metastatic Potential During the Malignant Transformation of Factor-Dependent CCL39 Lung Fibroblasts | Q43687864 | ||
| Characterization of the inhibitory effects of transforming growth factor-beta on a human colon carcinoma cell line. | Q43865651 | ||
| Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-beta 1. | Q43903303 | ||
| Alterations in c-myc expression in relation to maturational status of human colon carcinoma cells | Q44761925 | ||
| Conversion of a high molecular weight latent beta-TGF from chicken embryo fibroblasts into a low molecular weight active beta-TGF under acidic conditions | Q47216652 | ||
| A highly modular cloning vector for the analysis of eukaryotic genes and gene regulatory elements | Q48372769 | ||
| Identification of two distinct regulatory regions adjacent to the human β-interferon gene | Q48395961 | ||
| Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. | Q50904345 | ||
| Epithelial polarity, villin expression, and enterocytic differentiation of cultured human colon carcinoma cells: a survey of twenty cell lines. | Q52826934 | ||
| Different epidermal growth factor growth responses and receptor levels in human colon carcinoma cell lines | Q68100720 | ||
| Comparison of growth requirements of two human intratumoral colon carcinoma cell lines in monolayer and soft agarose | Q68132129 | ||
| Effects of growth stimulatory factors on mitogenicity and c-myc expression in poorly differentiated and well differentiated human colon carcinoma cells | Q69536992 | ||
| Immunodetection and modulation of cellular growth with antibodies against native transforming growth factor-beta 1 | Q69908789 | ||
| Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) secreted by cells in culture | Q69936661 | ||
| Growth Inhibitor from BSC-1 Cells Closely Related to Platelet Type β Transforming Growth Factor | Q72399491 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell biology | Q7141 |
| cell division | Q188909 | ||
| colon carcinoma | Q18554829 | ||
| P1104 | number of pages | 10 | |
| P304 | page(s) | 187-196 | |
| P577 | publication date | 1992-01-01 | |
| P1433 | published in | Journal of Cell Biology | Q1524550 |
| P1476 | title | TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector | |
| P478 | volume | 116 |
| Q24318523 | 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers |
| Q30449276 | A benign cultured colon adenoma bears three genetically altered colon cancer oncogenes, but progresses to tumorigenicity and transforming growth factor-beta independence without inactivating the p53 tumor suppressor gene |
| Q40019241 | A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma |
| Q40735877 | Activation of the TGFalpha autocrine loop is downstream of IGF-I receptor activation during mitogenesis in growth factor dependent human colon carcinoma cells |
| Q36531643 | Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor beta 1 |
| Q34136521 | Angiogenesis in breast cancer: the role of transforming growth factor beta and CD105. |
| Q71601446 | Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer |
| Q40789892 | Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells |
| Q78392687 | Autocrine TGFbeta supports growth and survival of human breast cancer MDA-MB-231 cells |
| Q53429145 | Autocrine transforming growth factor alpha provides a growth advantage to malignant cells by facilitating re-entry into the cell cycle from suboptimal growth states. |
| Q41335793 | Autocrine transforming growth factor beta 1 modulates the expression of integrin alpha 5 beta 1 in human colon carcinoma FET cells |
| Q57138517 | B-cell isotype control in atopy and asthma assessed with cDNA array technology |
| Q40879460 | Characterization of a newly established human pancreatic carcinoma cell line, UK Pan-1. |
| Q54157013 | Clonal heterogeneity of the sensitivity of human colon carcinoma cell lines to TGFβ isoforms |
| Q42470931 | Control of type II transforming growth factor-beta receptor expression by integrin ligation |
| Q34014701 | DEC1 is a downstream target of TGF-beta with sequence-specific transcriptional repressor activities |
| Q33962863 | Defects of TGF-beta receptor signaling in mammary cell tumorigenesis |
| Q41294837 | Demonstration That Mutation of the Type II Transforming Growth Factor β Receptor Inactivates Its Tumor Suppressor Activity in Replication Error-positive Colon Carcinoma Cells |
| Q71557045 | Differential control of expression of type I and type II receptors of transforming growth factor-beta in colon carcinoma cells |
| Q40069672 | Dysregulation of autocrine TGF-beta isoform production and ligand responses in human tumour-derived and Ha-ras-transfected keratinocytes and fibroblasts |
| Q40973299 | Efficacy and specificity of antisense laminin chain-specific expression vectors in blocking laminin induction by TGFbeta1: effect of laminin blockade on TGFbeta1-mediated cellular responses |
| Q40570950 | Endogenous control of cell cycle progression by autocrine transforming growth factor beta in breast cancer cells |
| Q36401309 | Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells |
| Q36644133 | Enhanced translational efficiency of a novel transforming growth factor beta 3 mRNA in human breast cancer cells |
| Q40801229 | Escape from negative regulation of growth by transforming growth factor beta and from the induction of apoptosis by the dietary agent sodium butyrate may be important in colorectal carcinogenesis |
| Q41110628 | Expression of transforming growth factor beta (TGFbeta) type III receptor restores autocrine TGFbeta1 activity in human breast cancer MCF-7 cells |
| Q41089111 | Expression of transforming growth factor beta type III receptor suppresses tumorigenicity of human breast cancer MDA-MB-231 cells |
| Q54127845 | Extracellular matrix-associated transforming growth factor-beta: role in cancer cell growth and invasion. |
| Q39586742 | GFAP promoter-driven RNA interference on TGF-β1 to treat liver fibrosis |
| Q62978063 | Gene interaction and single gene effects in colon tumour susceptibility in mice |
| Q46014736 | Growth inhibition of human pancreatic carcinoma cells by transforming growth factor beta-1. |
| Q41469446 | Growth suppression by transforming growth factor beta 1 of human small-cell lung cancer cell lines is associated with expression of the type II receptor |
| Q24536137 | HLTF gene silencing in human colon cancer |
| Q47870435 | IL-2 gene and antisense TGF-beta1 strategies counteract HSV-2 transformed tumor progression |
| Q36185927 | Identification of novel and differentially expressed MicroRNAs in goat enzootic nasal adenocarcinoma |
| Q55263243 | Improvement of macrophage dysfunction by administration of anti-transforming growth factor-beta antibody in EL4-bearing hosts. |
| Q24319995 | Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability |
| Q36544364 | Induction of KIAA1199/CEMIP is associated with colon cancer phenotype and poor patient survival. |
| Q36483438 | Integration of transforming growth factor beta and RAS signaling silences a RAB5 guanine nucleotide exchange factor and enhances growth factor-directed cell migration |
| Q41546005 | Interactions between interferon gamma and retinoic acid with transforming growth factor beta in the induction of immune recognition molecules |
| Q36233022 | Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression |
| Q35184753 | Knockdown of c-Fos suppresses the growth of human colon carcinoma cells in athymic mice |
| Q42315796 | Loss of TGFβ signaling promotes colon cancer progression and tumor-associated inflammation. |
| Q36392971 | Loss of expression of transforming growth factor beta in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion |
| Q42528758 | Mechanism of E1A-induced transforming growth factor-beta (TGF-beta) resistance in mouse keratinocytes involves repression of TGF-beta type II receptor transcription |
| Q38331867 | MicroRNA-mRNA interactions in colorectal cancer and their role in tumor progression |
| Q40876989 | Multiple autocrine factors including an extracellular matrix protein are required for the proliferation and spreading of human colon carcinoma cells in vitro |
| Q30469104 | Murine alpha-macroglobulins demonstrate divergent activities as neutralizers of transforming growth factor-beta and as inducers of nitric oxide synthesis. A possible mechanism for the endotoxin insensitivity of the alpha2-macroglobulin gene knock-ou |
| Q30467899 | Native and activated forms of alpha 2-macroglobulin increase expression of platelet-derived growth factor alpha-receptor in vascular smooth muscle cells. Evidence for autocrine transforming growth factor-beta activity |
| Q74582528 | Novel mutations in the polyadenine tract of the transforming growth factor beta type II receptor gene are found in a subpopulation of human pancreatic adenocarcinomas |
| Q41107314 | Opposite effect of stable transfection of bioactive transforming growth factor-beta 1 (TGF beta 1) versus exogenous TGF beta 1 treatment on expression of 92-kDa type IV collagenase in mouse skin squamous cell carcinoma CH72 cells. |
| Q40906841 | Overexpression of a dominant-negative type II TGFbeta receptor tagged with green fluorescent protein inhibits the effects of TGFbeta on cell growth and gene expression of mouse adrenal tumor cell line Y-1 and enhances cell tumorigenicity. |
| Q35011977 | Overexpression of the dynein light chain km23-1 in human ovarian carcinoma cells inhibits tumor formation in vivo and causes mitotic delay at prometaphase/metaphase |
| Q54333185 | Oxidative damage and transforming growth factor beta 1 expression in pretumoral and tumoral lesions of human intestine. |
| Q48000633 | Phenotypic consequences of transforming growth factor beta1 gene ablation in murine embryonic fibroblasts: autocrine control of cell proliferation and extracellular matrix biosynthesis |
| Q39630626 | Phosphatase PRL-3 Is a Direct Regulatory Target of TGFβ in Colon Cancer Metastasis |
| Q41391252 | Physical and biological characterization of a growth-inhibitory activity purified from the neuroepithelioma cell line A673 |
| Q45928244 | Primary aldosteronism can alter peripheral levels of transforming growth factor beta and tumor necrosis factor alpha. |
| Q54536390 | Progastrin1-80 stimulates growth of intestinal epithelial cells in vitro via high-affinity binding sites. |
| Q35618973 | Proliferation of mutators in A cell population |
| Q54141728 | Regulation of transforming growth factor-beta type II receptor expression in human breast cancer MCF-7 cells by vitamin D3 and its analogues. |
| Q71996824 | Release from quiescence stimulates the expression of integrin α5β1 which regulates DNA synthesis in human fibrosarcoma HT1080 cells |
| Q34963434 | Restoration of transforming growth factor-beta receptor II expression in colon cancer cells with microsatellite instability increases metastatic potential in vivo |
| Q33857574 | Role of Ras and Mapks in TGFbeta signaling |
| Q40856616 | Role of transforming growth factor beta in colorectal cancer |
| Q40415912 | Smad7 induces tumorigenicity by blocking TGF-beta-induced growth inhibition and apoptosis. |
| Q36416504 | TGF beta1 and related-Smads contribute to pulmonary metastasis of hepatocellular carcinoma in mice model |
| Q34639841 | TGF-Beta suppresses VEGFA-mediated angiogenesis in colon cancer metastasis |
| Q33804136 | TGF-beta and cancer. |
| Q41659039 | TGF-beta receptor signaling |
| Q38824306 | TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology |
| Q45345227 | TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice |
| Q38870781 | The Effects of miR-20a on p21: Two Mechanisms Blocking Growth Arrest in TGF-β-Responsive Colon Carcinoma. |
| Q40668566 | The importance of blood cell-vessel wall interactions in tumour metastasis |
| Q24658079 | The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers |
| Q41530670 | The role of growth regulatory aberrations in progression of human colon carcinoma |
| Q34832951 | The timing of TGF-β inhibition affects the generation of antigen-specific CD8+ T cells |
| Q40189889 | Transforming growth factor beta-1 in rectal tumour, mucosa and plasma in relation to radiotherapy and clinical outcome in rectal cancer patients |
| Q35544657 | Transforming growth factor beta/Smad3 signaling regulates IRF-7 function and transcriptional activation of the beta interferon promoter |
| Q40430362 | Transforming growth factor β and cancer |
| Q24793319 | Transforming growth factor-beta and breast cancer: Tumor promoting effects of transforming growth factor-beta |
| Q41056180 | Transforming growth factor-beta in GI neoplasia, wound healing and immune response |
| Q34438032 | Transforming growth factor-beta signal transduction in epithelial cells. |
| Q72386231 | Transforming growth factor-beta-mediated down-regulation of antitumor cytotoxicity of spleen cells from MOPC-315 tumor-bearing mice engaged in tumor eradication following low-dose melphalan therapy |
| Q47852627 | Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency. |
| Q35236115 | Transforming growth factor-beta: recent progress and new challenges |
| Q40009553 | Treatment of transforming growth factor-beta-insensitive mouse Renca tumor by transforming growth factor-beta elimination |
Search more.